A hybrid receptor has been constructed that is composed of the extracellular domain of the human insulin receptor fused to the transmembrane and cytoplasmic domains of the bacterial aspartate chemoreceptor. This hybrid protein can be expressed in rodent (CHO) cells and displays several functional features comparable to wild-type insulin receptor. It is localized to the cell surface, binds insulin with high affinity, forms oligomers, and is recognized by conformation-specific monoclonal antibodies. Although most of the expressed protein accumulates as a 180-kDa proreceptor, some processed 135-kDa receptor can be detected on the cell surface by covalent cross-linking. Expression of the hybrid receptor inhibits the insulin-activated uptake of 2-deoxyglucose by CHO cells. Thus, this hybrid is partially functional and can be processed; however, it is incapable of native transmembrane signaling. The results indicate that the intact domains of different types of receptors can retain some of the native features in a hybrid molecule but specific requirements will need to be satisfied for transmembrane signaling.
Signal transduction via membrane receptors involves discrete external and cytoplasmic domains with coordinated input and output functions. Receptors that appear to have a single or very few membrane spanning regions are an important class for study. Representative of this structure are the epidermal growth factor receptor (1), the insulin receptor (2, 3) , the low density lipoprotein receptors (4) , and the aspartate and serine receptors of bacterial chemotaxis (5, 6) . The receptor has a number of functions: to recognize a specific stimulus, to communicate information across the membrane, and to generate a signal that then is processed in the interior ofthe cell. To clarify the manner in which these processes are carried out, we have fused domains from two apparently unrelated receptors, the human insulin receptor (IR) and the bacterial aspartate receptor (AR), and analyzed the properties of the hybrid protein (IAR) .
The native IR is a disulfide-linked heterotetramer composed of two a and two / subunits (7) . Insulin binds to this receptor with high affinity and stimulates autophosphorylation of the / subunit on tyrosine residues. This tyrosine phosphokinase activity is characteristic of a class of transforming proteins encoded by oncogenes, including pp60src and the receptors for platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor 1 (8) . The primary sequence of the IR predicts a single polypeptide chain precursor encoding both the a and /8 subunits that is proteolytically processed during biosynthesis to generate a and / subunits (2, 3) . Consistent with prior biochemical studies, the sequence indicates that it is comprised of an extracellular domain containing all of the a and one-third of the 83 subunit, a stretch of hydrophobic amino acids that is presumed to span the membrane, and an intracellular domain that is the remaining two-thirds of the /3 subunit.
The AR of chemotaxis is likewise composed of an extracellular domain that binds aspartate with high affinity and specificity (6) . It contains two transmembrane segments, one near the N terminus and the other near the middle of the molecule, and a C-terminal cytoplasmic portion that generates the signal that controls flagella function. The cytoplasmic domain also becomes methylated at four distinct glutamate residues (9) that have been identified with the adaptation properties of the receptor (10, 11) .
The domains of the two widely different functional receptors were connected to form a chimeric protein by recombinant DNA methods. The external N-terminal portion of the IR was split near residue 921 in the /8 chain and attached to the C-terminal portion beginning with residue 171 of the AR; a new glycine residue is introduced at the junction. Other combinations of the IR and AR have been synthesized, and their properties will be reported subsequently.
MATERIALS AND METHODS
Construction of the JAR. The hybrid IAR cDNA was assembled in plasmid pECE, a 2.9-kilobase (kb) expression vector (12) with the following features: (i) a simian virus 40 early promoter for expression in mammalian cells, (ii) a polylinker that includes 5' HindIII and 3' Xba I sites not present in either the IR cDNA (2) or AR gene (6) , and (iii) 3 
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3' Xba I ends, was purified by electrophoresis on low-gelling temperature agarose (SeaPlaque; FMC, Rockland, ME).
The AR gene fragment used in this construction was derived from pRK41, which contains the AR gene as a 2.35-kb Cla I fragment cloned into the unique Cla I site of pBR322 (6) Here the first guanosine of the glycine codon is contributed by the Asp-922 codon of the IR cDNA [which is interrupted by the Aat II site of base pair 2983 (2)] and the second and third guanosines of the glycine codon are contributed by the Arg-170 codon of the AR [which is interrupted by the Sma I site at base pair 744 of the AR gene (6) ].
This DNA sequence was confirmed by subcloning a fragment (5' Pst I site of bp 2868 of IR cDNA, 3' Xba I site) of the hybrid cDNA containing this junction into M13-mpl8 (15) and determining its sequence by the dideoxy-chain terminator method (16) . The IAR hybrid protein thus contains 921 residues derived from the IR [all ofthe a subunit and all of the extracellular portion of the P3 subunit, except 8 amino acids prior to the transmembrane domain (2)]. A new glycine residue is created at the hybrid junction, which connects to 18 residues of the extracellular (periplasmic) domain of the aspartate receptor, the transmembrane domain (24 amino acids), and entire cytoplasmic domain (341 amino acids) of the bacterial protein (6) .
peIAR.1 DNA was introduced into wild-type Chinese hamster ovary (CHO) cells as a calcium phosphate precipitate with pSV2neo DNA as described (12, 14) . Primary transformants were selected by the use of the antibiotic G418 (GIBCO).
Total cellular RNA dot blots prepared from primary transformants were screened for the expression of the expected hybrid mRNA with an AR DNA probe (data not shown). One such transformant, CHO.IAR-4, which expressed the highest level of AR-related mRNA, was selected for further analysis.
Fluorescence-activated cell sorting (FACS), 125I-labeled insulin binding, purification of the hybrid TAR protein, metabolic labeling of cells, immunoprecipitations, and uptake of 2-deoxy[3H]glucose were performed as described (12) . Covalent cross-linking of 125I-labeled insulin to intact cells was as described in the legend to Fig. 4 .
RESULTS
To assess whether the IAR protein is expressed on the surface of the transfected cells, we employed indirect immunofluorescence and FACS (12) , using a monoclonal antibody (mAb) specific for the IR. Since the antibody blocks insulin binding to cells and only recognizes the native IR protein, it provides an assay for the native conformation of the extracellular domain of the IR (17) . Initial analysis of the CHO.JAR-4 cells (Chinese hamster ovary cells containing IAR-4) by FACS revealed a population (-'10% of the total) that had a fluorescent intensity 10-fold brighter than the controls. We enriched these cells by aseptically sorting the most intense cells (-2.5% ofthe total). These cells comprised a broad peak that was 7 times more fluorescent than the controls. Pure cell lines were generated from this population through subcloning by limiting dilution. One such cell line, hereafter referred to as IAR cells, exhibited a level of fluorescence approximately 2.5 times the control level, consistent with =2 x 104 receptors per cell ( Fig. 1; cf. ref. 12 ). These results with the IR mAb suggest that the extracellular domain of the IAR, which is anchored to the cell surface by the transmembrane domain of the bacterial receptor, has assumed a wild-type conformation. Furthermore, this IAR has a nearly wild-type affinity for insulin (Fig. 2) a (=135,000) and ,3 (-95,000) subunits (Fig. 3, lane 2) . These bands are not immunoprecipitated by normal mouse IgG (Fig.  3, lane 1) . In contrast, the monoclonal antibody to the human IR recognizes a single band of Mr %180,000 in IAR cells (Fig.  3, lane 4) , which is absent in the control (Fig. 3, lane 3 (Fig. 4) . Under reducing conditions, a single labeled band of 4135 kDa is visible in IAR cells incubated with 125I-labeled insulin alone (lane 1), and unlabeled insulin specifically displaced labeled insulin in this band (lane 2). The %135-kDa subunit of the endogenous rodent receptor is not visible under these conditions, since only -2-3 x 103 high-affinity IRs exist per cell (19) . Thus, despite the low level of IAR precursor processing observed in metabolic labeling experiments (cf. Fig. 3) , the IAR at the cell surface exhibits a mature a subunit. However, the presence of entirely heterologous domains has dramatically reduced the efficient processing of this hybrid IAR receptor.
How does the presence of the heterologous AR domains influence the quaternary structure of the IAR molecule?
Electrophoresis under nonreducing conditions of the 125i- (lanes 1 and 3) or presence (lanes 2 and 4) of 10 ,uM insulin. 125I-labeled insulin was then covalently crosslinked to its receptor by the addition of the cross-linking agent disuccinimidyl suberimidate (0.5 mM) for 15 min at 4°C. Reactions were terminated by the addition of 100 mM Tris HCl, pH 7.5. Cells were then washed, solubilized with 1% Triton X-100, clarified by centrifugation (10,000 x g, 10 min, 4°C), and boiled in 1% NaDodSO4 in the presence (lanes 3 and 4) or absence (lanes 1 and 2) of 5% (vol/vol) 2-mercaptoethanol. Proteins were analyzed by NaDodSO4/ PAGE (5% gel) and by autoradiography of the dried gel. Molecular sizes (in kDa) of protein standards are indicated.
Biochemistry: Effis et al. were incubated in a reaction including bacterial phospholipids, glycerol, purified bacterial methylase, S-[3H]adenosylmethionine, and with or without 1 kLM porcine insulin. We have thus far been unable to detect receptor methylation in such a system. Similarly, the solubilization ofcell membranes by protocols employed for mammalian IRs (17) failed to yield detectable methylation.
DISCUSSION
The formation of a hybrid receptor containing the external portion of the IR and the cytoplasmic portion of the AR as shown in Fig. 6 has revealed a number of significant features of these receptors. In the first place the external domains of the IR appear to fold into approximately the native conformation, as indicated by insulin binding and a conformationspecific monoclonal antibody. This is surprising, since the transmembrane portion and 8 extracellular amino acids ofthe IR have been replaced by the transmembrane portion and an extra 19 external amino acids of the AR. Despite these changes the folding of the insulin-binding portion of the receptor is not seriously altered.
Secondly the single transmembrane portion of residues 189-212 of the AR appears to be sufficient to anchor the protein in the membrane. Previous studies have demonstrated that the AR anchors itself in the membrane of bacterial cells, but those receptors contained two transmembrane sequences. Apparently only one of the two is sufficient for anchoring.
The replacement of the mammalian C-terminal domain by the bacterial one apparently does not prevent either expression or processing. This result is consistent with other studies in which C-terminal sequences have proven to be innocuous but also contrasts with studies on proteins in which such domains are critical (21) . The processed receptor still gets to the cell surface but it does so with much less efficiency, an indication that the C-terminal domains play a role in the sorting process. Furthermore, it is striking that the IAR actually interferes with the endogenous insulin response of the rodent cells. This may be due to an inhibition of rodent IR biosynthesis or other complex interactions. However, the possibility of mixed oligomers between rodent IR and IAR subunits is appealing and may hint at the importance of quaternary structure in signal transduction.
The alteration of the sequence also inhibits the transmembrane signaling. Whether the added external amino acids are responsible or whether other factors prevent this transmission must await future experiments.
Chimeric proteins of various types have been made for antibodies (22) , receptors (23) , enzymes (24) , and other proteins. In most of those cases either short signal sequences were substituted or similar domains were interchanged. In analogous studies, truncated receptors have been made in the laboratory (6, 12) or in nature by oncogenic viruses (25) to generate defective proteins. For example, an N-terminal portion of the AR retains aspartate binding properties (26) , and proteins with various lengths of the C-terminal portion deleted produce proteins that signal but do not adapt (6) . In the case reported here, two very different structural domains have been interchanged. The chance that they would be functional was enhanced by the common structural feature of the single hydrophobic transmembrane sequence. Apparently this similarity was sufficient to retain many of the properties of the individual domains. However, the receptor fusion was sufficiently imperfect to prevent detectable transmembrane signaling. Permutations can now be made on this basic design by assembling the domains at different junctions to reveal the fundamental nature of the signaling mechanism.
